A Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma
Condition:   Multiple Myeloma Interventions:   Drug: Cevostamab;   Drug: XmAb24306;   Drug: Tocilizumab Sponsor:   Genentech, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2022 Category: Research Source Type: clinical trials

Tocilizumab Acute Chest
Conditions:   Sickle Cell Disease;   Acute Chest Syndrome Intervention:   Drug: Tocilizumab Sponsor:   University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2022 Category: Research Source Type: clinical trials